Cargando…
Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis
BACKGROUND: The prognosis of hepatocellular carcinoma remains poor even after curative resection and it has no effective adjuvant therapy. AIM: This meta-analysis aimed to assess efficacy of sorafenib as adjuvant therapy for patients with hepatocellular carcinoma after resection. MATERIALS AND METHO...
Autores principales: | Shang, Jin, Xu, Shanling, Zhang, Jiaxing, Ran, Xuting, Bai, Lang, Tang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752555/ https://www.ncbi.nlm.nih.gov/pubmed/29312642 http://dx.doi.org/10.18632/oncotarget.21299 |
Ejemplares similares
-
Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis
por: Cao, Guangchao, et al.
Publicado: (2015) -
Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China: a comprehensive meta-analysis
por: Li, Zhijun, et al.
Publicado: (2021) -
Sorafenib in the treatment of patients with hepatocellular carcinoma (HCC) and microvascular infiltration: a systematic review and meta-analysis
por: Gu, Wang, et al.
Publicado: (2020) -
Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials
por: Tan, Darren Jun Hao, et al.
Publicado: (2023) -
Transcatheter hepatic arterial chemoembolization and sorafenib for hepatocellular carcinoma: a meta-analysis of randomized, double-blind controlled trials
por: Li, Jun, et al.
Publicado: (2017)